AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 99 filers reported holding AVROBIO INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $124,000 | -40.4% | 22,244 | -4.9% | 0.06% | -36.0% |
| Q2 2021 | $208,000 | -26.2% | 23,398 | +5.2% | 0.09% | -27.7% |
| Q1 2021 | $282,000 | -7.5% | 22,244 | +1.8% | 0.12% | -6.3% |
| Q4 2020 | $305,000 | +66.7% | 21,853 | +55.5% | 0.13% | +32.3% |
| Q3 2020 | $183,000 | -34.2% | 14,055 | -11.9% | 0.10% | -27.3% |
| Q2 2020 | $278,000 | +8.6% | 15,955 | -2.9% | 0.13% | +25.7% |
| Q1 2020 | $256,000 | -32.5% | 16,434 | -12.7% | 0.10% | +69.4% |
| Q4 2019 | $379,000 | +44.1% | 18,829 | +0.9% | 0.06% | +17.0% |
| Q3 2019 | $263,000 | -17.8% | 18,656 | -5.3% | 0.05% | -20.9% |
| Q2 2019 | $320,000 | +33.9% | 19,695 | +81.5% | 0.07% | -86.8% |
| Q1 2019 | $239,000 | +17.2% | 10,850 | -11.6% | 0.51% | +1354.3% |
| Q4 2018 | $204,000 | – | 12,277 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 4,520,863 | $5,968,000 | 0.76% |
| Aisling Capital Management LP | 1,009,779 | $1,333,000 | 0.72% |
| MPM BioImpact LLC | 647,918 | $855,000 | 0.23% |
| GMT CAPITAL CORP | 2,594,914 | $3,425,000 | 0.22% |
| New Leaf Venture Partners, L.L.C. | 315,550 | $417,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 338,422 | $447,000 | 0.06% |
| Penn Mutual Asset Management, LLC | 37,306 | $49,000 | 0.06% |
| Eversept Partners, LP | 295,369 | $389,887 | 0.03% |
| XTX Topco Ltd | 23,289 | $31,000 | 0.01% |
| Colonial River Wealth Management, LLC | 17,636 | $23,000 | 0.01% |